Skip to main content

Chief investment officers persist with GenAI tools despite ‘blind spots’

Trading heads from JP Morgan, UBS, and M&G Investments explained why their firms were bullish on GenAI, even as “replicability and reproducibility” challenges persist.

ai-selection-0120.jpg

Fabiana Fedeli has more than two decades of portfolio management experience. In 2021, she joined M&G Investments in the then-newly created role of chief investment officer for equities, after serving a stint at Robeco Asset Management, where she was global head of fundamental equities.

In addition to equities, she has added multi-assets and sustainability trading to her CIO position. Part of her remit includes M&G’s Global Maxima Fund, a machine learning-based strategy that marries AI and human

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here